Somebody is on a mission to punish
this stock...a flurry of shares went
off and took ARIA down to 1 1/16 just
now.
Spoke to LaMarche yesterday...the Ariad-
Genovo alliance is still intact, a couple
of us were worried about that, but apparently
everything is fine. I would love to have
heard they've found a pharma partner for
ARGENT+Genovo's AAV vector...but shucks,
no inside info for me;-)
The PNAS paper is impressive...I'd encourage
everybody in Ariad stock to get a copy--the
company sent me one...plus I got a copy via
email, so I'm in good shape. It is a little
hard to read for non-scientists in places,
but you will love the graphs. If somebody
wants to really go nuts...maybe start a thread
to compare the various regulation systems.
Ariad seems to have the lead with ARGENT for
now--in fact, I read a few abstracts from other
Gene therapy companies last night...and did not
find anything that shows expression as long as
what Ariad/Genovo has...not by a long shot. However,
I only looked at a few abstracts that jumped out
at me...getting to them all would be a major under-
taking...and like the Ariad PNAS paper...you sort
of need to have the whole paper in front of you--
I can only get the abstracts.
You know...if this latest paper had monkeys, I'd bet
ARIA would be trading at $4 again today, oh well.
Looks like the stock is going to continue to be
punished, who can say why? Maybe it is just time
to call it quits...halve all your positions and
walk away. I'm not willing to get that drastic
with my Ariad shares, but I did raise cash today
where I could.
I may have to do a little daytrading to get
my account back up...and at least cash cant hurt
you. I basically sold all my extra trading shares
...but of course I do retain core positions in a
handful of micro biotechs...including probably too
much Ariad.
Well, good luck to all. The stock is really
looking sickly. I don't know what to say about
that, I tried, maybe I blew it. At least it has
been an education.
I'll come back to the thread after I see some news,
or that mid-year shareholder letter. Frankly, right
now I don't even want to look at the quotes, scary
stuff. |
